D H Solomon

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy
    D H Solomon
    Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 38:969-76. 2001
  2. pmc A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial
    D H Solomon
    Division of Rheumatology, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Osteoporos Int 21:137-44. 2010
  3. pmc Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?
    E Losina
    Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopaedic Surgery, Brigham and Women s Hospital, Boston, MA, USA Section of Clinical Sciences, Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA Boston University School of Public Health, Boston, MA, USA Electronic address
    Osteoarthritis Cartilage 22:415-30. 2014
  4. pmc Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series
    E Mercer
    Division of Rheumatology, Brigham and Women s Hospital, 75 Francis Street, PBB B3, Boston, MA 02115, USA
    Calcif Tissue Int 93:241-8. 2013
  5. doi request reprint Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Osteoporos Int 24:237-44. 2013
  6. pmc Comparative gastrointestinal safety of weekly oral bisphosphonates
    S M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Osteoporos Int 20:1735-47. 2009
  7. pmc The relation between bisphosphonate use and non-union of fractures of the humerus in older adults
    D H Solomon
    Division of Pharmacoepidemiology, Harvard Medical School, Boston, MA, USA
    Osteoporos Int 20:895-901. 2009
  8. doi request reprint Antidepressants and fracture risk in older adults: a comparative safety analysis
    J J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 89:880-7. 2011
  9. ncbi request reprint Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease
    D M Charytan
    Renal Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Kidney Int 71:938-45. 2007
  10. ncbi request reprint Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment
    D H Solomon
    Division of Rheumatology, Allergy, Immunology, Robert B Brigham Multipurpose Arthritis and Musculoskeletal Diseases Center, Boston, Massachusetts, USA
    J Rheumatol 27:1496-500. 2000

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy
    D H Solomon
    Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 38:969-76. 2001
    ..This study was designed to determine whether patient characteristics collected at presentation can identify which patients benefit from immediate coronary angiography and revascularization...
  2. pmc A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial
    D H Solomon
    Division of Rheumatology, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Osteoporos Int 21:137-44. 2010
    ..Recruitment and randomization have been successful. Also, the counseling intervention has been well accepted by subjects randomized to this treatment arm...
  3. pmc Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?
    E Losina
    Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopaedic Surgery, Brigham and Women s Hospital, Boston, MA, USA Section of Clinical Sciences, Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA Boston University School of Public Health, Boston, MA, USA Electronic address
    Osteoarthritis Cartilage 22:415-30. 2014
    ..We sought to determine the target populations and drug efficacy, toxicity, cost, and initiation age thresholds under which a pharmacologic regimen for knee osteoarthritis (OA) prevention could be cost-effective...
  4. pmc Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series
    E Mercer
    Division of Rheumatology, Brigham and Women s Hospital, 75 Francis Street, PBB B3, Boston, MA 02115, USA
    Calcif Tissue Int 93:241-8. 2013
    ..The findings of this study confirm that BRONJ primarily affects the mandible, a substantial minority present without pain, and patients typically improve with treatment...
  5. doi request reprint Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Osteoporos Int 24:237-44. 2013
    ..We examined the literature and two new cohorts for BONJ. The literature suggests an incidence rate of 0.028 % to 4.3 %. Our cohort studies found an incidence of 0.02 % (95 % CI 0.004 %-0.11 %)...
  6. pmc Comparative gastrointestinal safety of weekly oral bisphosphonates
    S M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Osteoporos Int 20:1735-47. 2009
    ..We compared the gastrointestinal safety between weekly alendronate and weekly risedronate and found no important difference between new users of these agents...
  7. pmc The relation between bisphosphonate use and non-union of fractures of the humerus in older adults
    D H Solomon
    Division of Pharmacoepidemiology, Harvard Medical School, Boston, MA, USA
    Osteoporos Int 20:895-901. 2009
    ..37, 95% confidence interval (CI) 1.13-4.96]. Clinicians might consider waiting for several months before introduction of a bisphosphonate after a fracture...
  8. doi request reprint Antidepressants and fracture risk in older adults: a comparative safety analysis
    J J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 89:880-7. 2011
    ..Although SSRI use was associated with the highest rate of fractures, variation in fracture risk across specific antidepressant medications did not depend on affinity for serotonin transport receptors...
  9. ncbi request reprint Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease
    D M Charytan
    Renal Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Kidney Int 71:938-45. 2007
    ..However, the clinical features of MI do not account for its underuse in MI patients with CKD Stages 4/5. Whether reduced use of angiography in patients with advanced CKD is justified must be evaluated in formal risk-benefit analyses...
  10. ncbi request reprint Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment
    D H Solomon
    Division of Rheumatology, Allergy, Immunology, Robert B Brigham Multipurpose Arthritis and Musculoskeletal Diseases Center, Boston, Massachusetts, USA
    J Rheumatol 27:1496-500. 2000
    ..We examined the medications used by women before and after bone densitometry to determine whether patient or physician factors were associated with appropriate osteoporosis therapy...
  11. pmc Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
    E Losina
    Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham and Women s Hospital, Boston, MA 02115, USA
    Osteoarthritis Cartilage 21:655-67. 2013
    ..Disease-modifying osteoarthritis drugs (DMOADs) are under development. Our goal was to determine efficacy, toxicity, and cost thresholds under which DMOADs would be a cost-effective knee OA treatment...
  12. doi request reprint Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule
    D H Solomon
    Division of Rheumatology, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Osteoporos Int 22:1737-43. 2011
    ..When combined into a summative score, 62% with seven or more points on the score demonstrated very low adherence. This compares with 17% subjects with fewer than seven points (c-statistic = 0.74)...
  13. ncbi request reprint A computer based intervention to reduce unnecessary serologic testing
    D H Solomon
    Robert B Brigham Multipurpose Arthritis and Musculoskeletal Diseases Center, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Rheumatol 26:2578-84. 1999
    ....
  14. ncbi request reprint Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center
    D H Solomon
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 221 Longwood Ave, Suite 341, Boston, MA 02115, USA
    Arch Intern Med 161:1897-902. 2001
    ..We tested the efficacy of a targeted one-on-one educational program ("academic detailing") designed to improve the appropriateness of broad-spectrum antibiotic use...
  15. ncbi request reprint HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
    P S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 221 Longwood Ave, Boston, MA 02115
    JAMA 283:3211-6. 2000
    ....
  16. pmc Nonoccupational risk factors for carpal tunnel syndrome
    D H Solomon
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. 02115, USA
    J Gen Intern Med 14:310-4. 1999
    ..Further investigation in detailed clinical studies will be necessary to confirm whether changes in corticosteroid use and hormone replacement therapy offer additional means of risk reduction for this common condition...
  17. pmc Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review
    T Gleeson
    Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, PBB B3, Boston, MA 02115, USA
    Osteoporos Int 20:2127-34. 2009
    ..Few interventions were efficacious, and no clear trends regarding successful intervention techniques were identified. However, periodic follow-up interaction between patients and health professionals appeared to be beneficial...
  18. ncbi request reprint Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
    S Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 021205, USA
    Aliment Pharmacol Ther 30:253-64. 2009
    ..There remain concerns about the safety of infliximab therapy in patients with inflammatory bowel disease (IBD)...
  19. ncbi request reprint Referrals for musculoskeletal disorders: patterns, predictors, and outcomes
    D H Solomon
    Robert B Brigham Multipurpose Arthritis and Musculoskeletal Diseases Center, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Rheumatol 28:2090-5. 2001
    ..To examine factors associated with musculoskeletal referral and determine whether referral influences clinical outcomes...
  20. ncbi request reprint Uric acid lowering therapy: prescribing patterns in a large cohort of older adults
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Ann Rheum Dis 67:609-13. 2008
    ..Uric acid lowering therapy (UALT) is considered a chronic treatment for gout. Relatively little is known about adherence to UALT...
  21. pmc Measuring quality of care for rheumatic diseases using an electronic medical record
    J C Agnew-Blais
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Rheum Dis 68:680-4. 2009
    ....
  22. ncbi request reprint Postfracture interventions disseminated through health care and drug insurers: attempting to integrate fragmented health care delivery
    D H Solomon
    Division of Rheumatology, Brigham and Women s Hospital, 75 Francis Street, PBB B3, Boston, MA 02115, USA
    Osteoporos Int 22:465-9. 2011
    ..The strengths and weaknesses of each of these potential levers for improvement were explored. Postfracture osteoporosis care is sub-optimal and challenging to improve in fragmented health care delivery systems...
  23. ncbi request reprint Techniques to improve physicians' use of diagnostic tests: a new conceptual framework
    D H Solomon
    Department of Medicine, Robert B Brigham Multipurpose Arthritis and Musculoskeletal Diseases Center, Brigham and Women s Hospital, Harvard School of Medicine, Boston, MA 02115, USA
    JAMA 280:2020-7. 1998
    ....
  24. pmc Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis
    N A Shadick
    Division of Rheumatology, Immunology, Allergy, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Ann Rheum Dis 66:1497-502. 2007
    ....
  25. ncbi request reprint Access to bone mineral density testing in patients at risk for osteoporosis
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Osteoporos Int 17:1749-54. 2006
    ..We assessed whether access to bone mineral density (BMD) testing was a predictor of osteoporosis management in an at-risk population of patients from New Jersey...
  26. ncbi request reprint Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosis
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, Boston, MA, USA
    Osteoporos Int 25:2255-62. 2014
    ....
  27. pmc Patterns of cardiovascular risk in rheumatoid arthritis
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Ann Rheum Dis 65:1608-12. 2006
    ..This study investigated the relative risk of myocardial infarction, stroke and CVD mortality in adults with rheumatoid arthritis compared with adults without rheumatoid arthritis across age groups, sex and prior CVD event status...